Importance of Early Aggressive Glucose Control - Approach in 2026 - Video
Overview
In this episode of The Diabetes Wellness Forum, titled "Importance of Early Aggressive Glucose Control – Approach in 2026," Dr Nandita Mohan from Medical Dialogues is in conversation with Dr. Usha Ayyagiri, Senior Consultant in Diabetes, Endocrinology and General Medicine, Apollo Sugar Clinics and Apollo Speciality Hospitals, OMR, Chennai; Apollo Proton Cancer Care Centre, OMR, Chennai and Dr. S Sridhar, Professor and Head, Department of Endocrinology and Metabolism, Madurai Medical College, Madurai & Visiting Consultant Vadamalayan Hospital, Madurai to discuss critical aspects of diabetes care in 2026.
The burden of type 2 diabetes in young individuals is increasing in India, and the disease often progresses rapidly, leading to microvascular and macrovascular complications. This makes early and aggressive glucose control critical in order to mitigate complications and preserve long-term outcomes. This episode focuses on real-world approaches to early aggressive glucose control in 2026.
During this episode, the experts address three key clinical questions:
What is the importance of aggressive blood glucose control in young uncontrolled T2DM patients?
What is the benefit of beta-cell preserving pharmacological regimens such as Empagliflozin Sitagliptin Metformin early in young uncontrolled T2DM patients?
In which patient profiles would you consider Empagliflozin Sitagliptin Metformin FDC?
Speakers
